Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)

Astes

Status

Completed

Conditions

Obesity

Smoking

Obstructive Sleep Apnea

Treatments

Other: Benzodiazepine use

Other: Obesity

Other: Smoking

Study type

Observational

Funder types

Other

Identifiers

NCT02539264

DEES-OSA

Details and patient eligibility

About

In this study the investigators will analyze the influence of smoking, benzodizepine use, and obesity among patients with severe Obstructive Sleep Apnea (sOSA).

Full description

This study is a retrospective study. Patients enrolled: all patients with a PSG (polysomnography) between 1st January 2014 and 30th June 2015.

First analysis: influence of smoking, benzodiazepine use, and obesity on the AHI (Apnea Hypopnea Index: the number of apnea and hypopnea per hour of sleep).

Second analysis: only among patients with sOSA: influence of smoking, benzodiazepine use, and obesity on sleep fragmentation and night oximetry.

Enrollment

920 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria